Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer

Breast Cancer Research and Treatment

Volumn 95, Issue 3, 2006, Pages 279-293

  Fleissig, Anne ^a   Fallowfield, Lesley J ^a,e   Langridge, Carolyn I ^a   Johnson, Leigh ^a   Newcombe, Robert G ^b   Dixon, J Michael ^c   Kissin, Mark ^d   Mansel, Robert E ^b  

^a BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c WESTERN GENERAL HOSPITAL   (United Kingdom)

^d ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

^e UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

Axilla surgery; Breast cancer; Quality of life; Sentinel lymph node biopsy

Indexed keywords

ADULT; AGED; ANXIETY; ARM MOVEMENT; ARM SWELLING; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER PATIENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; EARLY CANCER; EVALUATION; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PHYSICAL CAPACITY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SAMPLING; SCORING SYSTEM; SENTINEL LYMPH NODE BIOPSY; STANDARD; STATE TRAIT ANXIETY INVENTORY; WELLBEING;

ADULT; AGED; AGED, 80 AND OVER; ARM; AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; MORBIDITY; POSTOPERATIVE PERIOD; QUALITY OF LIFE; QUESTIONNAIRES; SENTINEL LYMPH NODE BIOPSY; TREATMENT OUTCOME;

EID: 33645227010     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-005-9025-7     Document Type: Article

References (45)

1. Mansel RE, Goyal A: European studies on breast lymphatic mapping. Semin Oncol 31: 304-310, 2004
2. Mansel RE, Goyal A, Fallowfield L, Newcombe RG: Sentinel node biopsy versus standard axillary treatment: results of the randomized multicenter UK ALMANAC trial. Abstracts of the 27th Annual San Antonio Breast Cancer Symposium. December 8-11, 2004, San Antonio, Texas, USA. Breast Cancer Res Treat 88(Suppl 1): S1-S265, 2004
3. Mansel RE, Goyal A, Fallowfield L, Newcombe RG: First results of the randomized multicenter ALMANAC trial. Abstracts of the 40th Annual Meeting of the American Society of Clinical Oncology. New Orleans, Louisiana, USA, June 5-8, 2004. J Clin Oncol 22: 1s-1069s, 2004
4. Schrenk P, Rieger R, Shamiyeh A, Wayand W: Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 88: 608-614, 2000
5. Temple LK, Baron R, Cody HS, III, Fey JV, Thaler HT, Borgen PI, Heerdt AS, Montgomery LL, Petrek JA, Van Zee KJ: Sensory morbidity after sentinel lymph node biopsy and axillary dissection: a prospective study of 233 women. Ann Surg Oncol 9: 654-662, 2002
6. Swenson KK, Nissen MJ, Ceronsky C, Swenson L, Lee MW, Tuttle TM: Comparison of side effects between sentinel lymph node and axillary lymph node dissection for breast cancer. Ann Surg Oncol 9: 745-753, 2002
7. Haid A, Koberle-Wuhrer R, Knauer M, Burtscher J, Fritzsche H, Peschina W, Jasarevic Z, Ammann M, Hergan K, Sturn H, et al.: Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only: a comparative evaluation. Breast Cancer Res Treat 73: 31-36, 2002
8. Burak WE, Hollenbeck ST, Zervos EE, Hock KL, Kemp LC, Young DC: Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer. Am J Surg 183: 23-27, 2002
9. Baron RH, Fey JV, Borgen PI, Van Zee KJ: Eighteen sensations after breast cancer surgery: a two-year comparison of sentinel lymph node biopsy and axillary lymph node dissection. Oncol Nurs Forum 31: 691-698, 2004
10. Peintinger F, Reitsamer R, Stranzl H, Ralph G: Comparison of quality of life and arm complaints after axillary lymph node dissection vs. sentinel lymph node biopsy in breast cancer patients. Br J Cancer 89: 648-652, 2003
11. Giuliano AE, Haigh PI, Brennan MB, Hansen NM, Kelley MC, Ye W, Glass EC, Turner RR: Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol 18: 2553-2559, 2000
12. Kuehn T, Klauss W, Darsow M, Regele S, Flock F, Maiterth C, Dahlbender R, Wendt I, Kreienberg R: Long-term morbidity following axillary dissection in breast cancer patients-clinical assessment, significance for life quality and the impact of demographic, oncologic and therapeutic factors. Breast Cancer Res Treat 64: 275-286, 2000
13. Haid A, Kuehn T, Konstantiniuk P, Koberle-Wuhrer R, Knauer M, Kreienberg R, Zimmermann G: Shoulder-arm morbidity following axillary dissection and sentinel node only biopsy for breast cancer. Eur J Surg Oncol 28: 705-710, 2002
14. Arnaud S, Houvenaeghel G, Moutardier V, Butarelli M, Martino M, Tallet A, Braud AC, Jacquemier J, Julian-Reynier C, Brenot-Rossi I: Patients' and surgeons' perspectives on axillary surgery for breast cancer. Eur J Surg Oncol 30: 735-743, 2004
15. Warmuth MA, Bowen G, Prosnitz LR, Chu L, Broadwater G, Peterson B, Leight G, Winer EP: Complications of axillary lymph node dissection for carcinoma of the breast: a report based on a patient survey. Cancer 83: 1362-1368, 1998
16. Blanchard DK, Donohue JH, Reynolds C, Grant CS: Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch Surg 138: 482-487, discussion 487-488, 2003
17. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, Intra M, Veronesi P, Robertson C, Maisonneuve P, et al.: A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349: 546-553, 2003
18. Rietman JS, Dijkstra PU, Geertzen JHB, Baas P, de Vries J, Dolsma WV, Groothoff JW, Eisma WH, Hoekstra HJ: Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer. Ann Surg Oncol 11: 1018-1024, 2004
19. Schijven MP, Vingerhoets AJ, Rutten HJ, Nieuwenhuijzen GA, Roumen RM, van Bussel ME, Voogd AC: Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. Eur J Surg Oncol 29: 341-350, 2003
20. Ronka R, von Smitten K, Tasmuth T, Leidenius M: One-year morbidity after sentinel node biopsy and breast surgery. Breast 14: 28-36, 2005
21. Liljegren G, Holmberg L: Arm morbidity after sector resection and axillary dissection with or without postoperative radiotherapy in breast cancer stage I. Results from a randomised trial. Uppsala-Orebro Breast Cancer Study Group. Eur J Cancer 33: 193-199, 1997
22. Hack TF, Cohen L, Katz J, Robson LS, Goss P: Physical and psychological morbidity after axillary lymph node dissection for breast cancer. J Clin Oncol 17: 143-149, 1999
23. Ververs JM, Roumen RM, Vingerhoets AJ, Vreugdenhil G, Coebergh JW, Crommelin MA, Luiten EJ, van Repelaer Driel OJ, Schijven M, Wissing JC, et al.: Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer. Eur J Cancer 37: 991-999, 2001
24. Engel J, Kerr J, Schlesinger-Raab A, Sauer H, Holzel D: Axilla surgery severely affects quality of life: results of a 5-year prospective study in breast cancer patients. Breast Cancer Res Treat 79: 47-57, 2003
25. Dubernard G, Sideris L, Delaloge S, Marsiglia H, Rochard F, Travagli JP, Mathieu MC, Lumbroso J, Spielmann M, Garbay JR, et al.: Quality of life after sentinel lymph node biopsy in early breast cancer. Eur J Surg Oncol 30: 728-734, 2004
26. Keramopoulos A, Tsionou C, Minaretzis D, Michalas S, Aravantinos D: Arm morbidity following treatment of breast cancer with total axillary dissection: a multivariated approach. Oncology 50: 445-449, 1993
27. Kiel KD, Rademacker AW: Early-stage breast cancer: arm edema after wide excision and breast irradiation. Radiology 198: 279-283, 1996
28. Coster S, Poole K, Fallowfield LJ: The validation of a quality of life scale to assess the impact of arm morbidity in breast cancer patients post-operatively. Breast Cancer Res Treat 68: 273-282, 2001
29. Spielberger C, Gorsuch R, Lusherne R, Vagg P, Jacobs G: Manual for the State-trait Anxiety Inventory (form Y). Consulting Psychologists Press, Palo Alto, CA, 1983
30. Cella D, Tulsky D, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen S, Winicour P, Brannon J: The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11: 570-579, 1993
31. Brady MJ, Cella DF, Mo F, Bonomi AE, Tulsky DS, Lloyd SR, Deasy S, Cobleigh M, Shiomoto G: Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument. J Clin Oncol 15: 974-986, 1997
32. Fallowfield L, Cella D, Cuzick J, Francis S, Locker G, Howell A: Quality of life of postmenopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) adjuvant breast cancer trial. J Clin Oncol 22: 4261-4271, 2004
33. Eton DT, Cella D, Yost KJ, Yount SE, Peterman AH, Neuberg DS, Sledge GW, Wood WC: A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scale. J Clin Epidemiol 57: 898-910, 2004
34. Cella D, Eton DT, Fairclough DL, Bonomi P, Heyes AE, Silberman C, Wolf MK, Johnson DH: What is a clinically meaningful change on the Functional Assessment of Cancer Therapy-Lung (FACT-L) questionnaire?: results from Eastern Cooperative Oncology Group (ECOG) study 5592. J Clin Epidemiol 55: 285-295, 2002
35. Passik SD, Newman ML, Brennan M, et al.: Predictors of psychological distress, sexual dysfunction and physical functioning among women with upper extremity lymphedema related to breast cancer. Psycho-Oncol 4: 255-263, 1995
36. Voogd AC, Ververs JM, Vingerhoets AJ, Roumen RM, Coebergh JW, Crommelin MA: Lymphoedema and reduced shoulder function as indicators of quality of life after axillary lymph node dissection for invasive breast cancer. Br J Surg 90: 76-81, 2003
37. Edwards TL: Prevalence and aetiology of lymphoedema after breast cancer treatment in southern Tasmania. Aust NZ J Surg 70: 412-418, 2000
38. Poole K, Fallowfield LJ: The psychological impact of post-operative arm morbidity following axillary surgery for breast cancer: a critical review. Breast 11: 81-87, 2002
39. Maunsell E, Brisson J, Deschenes L: Arm problems and psychological distress after surgery for breast cancer. Can J Surg 36: 315-320, 1993
40. Fallowfield L: Offering choice of surgical treatment to women with breast cancer. Patient Educ Couns 30: 209-214, 1997
41. Hatcher MB, Fallowfield L, A'Hern R: The psychosocial impact of bilateral prophylactic mastectomy: prospective study using questionnaires and semistructured Interviews. BMJ 322: 76, 2001
42. Galper SR, Lee SJ, Tao ML, Troyan S, Kaelin CM, Harris JR, Weeks JC: Patient preferences for axillary dissection in the management of early-stage breast cancer. J Natl Cancer Inst 92: 1681-1687, 2000
43. Asaad M, Tamer M, Mokbel K: British women's choice between sentinel node biopsy and axillary node clearance for breast cancer. Curr Med Res Opin 19: 570-574, 2003
44. Gan S, Magarey C, Schwartz P, Papadatos G, Graham P, Vallentine J: Women's choice between sentinel lymph node biopsy and axillary clearance. ANZ J Surg 72: 110-113, 2002